The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
The technology, based on the Nano-Ghosts platform, makes it possible to reduce the drug dose a million-fold without reducing its efficacy. Researchers in the Faculty of Biotechnology and Food Engineering at the Technion developed a technology that inhibits development of melanoma using one-millionth of the active ingredient. The study, published in Advanced Functional Materials, was led by Professor Marcelle Machluf, dean of the faculty, and Ph.D. student Lior Levy. This development is a significant breakthrough in the field of immunotherapy — an innovative medical approach that uses the body’s own immune system to destroy cancer cells. Immunotherapy can destroy cancer…
Technion students don’t wait until graduation to make an impact on the world. Students from the Faculty of Biomedical Engineering recently showed off an array of initiatives from a tool that can detect cardiovascular disease to ingenious ways to fight COVID-19 — intriguing and lifesaving projects that could change the world.
Pictured above: Dr. Hanan Abumanhal Masarweh and Prof. Avi Schroeder Researcher behind the discovery is Dr. Hanan Abumanhal Masarweh, of the Russell Berrie Nanotechnology Institute at the Technion. She received her Ph.D. for her research under the supervision of Professor Avi Schroeder of the Technion’s Wolfson Faculty of Chemical Engineering. Baking soda, that simple product available at any supermarket, could revolutionize breast cancer treatment, according to Technion researchers who have found that this substance changes the acidity of the cancerous tumor and thus increases the efficacy of chemotherapy. The researcher behind the intriguing study is Dr. Hanan Abumanhal Masarweh. In…
When Associate Professor Avi Schroeder, a member of the Wolfson Faculty of Chemical Engineering and head of the Louis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, encountered a challenge differentiating between live cells extracted from tumors and dead cells inside them, assistance came from Professor Yuval Shaked. He provided valuable laboratory assistance that not only resolved the problem but pointed toward a new technique enhancing the study of relatively hard-to-penetrate tumors, such as those associated with pancreatic cancer. “The Rappaport Technion Integrated Cancer Center’s collaborative and cross-disciplinary approach to cancer research—involving outstanding medical doctors, engineers and basic…
Relive this lively discussion about the mind-body connection with Associate Professor Asya Rolls M.Sc.’02. An expert in sleep deprivation and brain research, Prof. Rolls explains how positive thinking can boost healing and immunity, impacting even the body’s ability to fight off cancer cells. Learn more about Prof. Rolls’ fascinating research by clicking the video above. […]
When treating cancer, researchers are always searching for ways to remove cancer cells while minimizing damage to the rest of the body. One possible approach is to find processes unique to cancer cells, and which would allow specific targeting. If such a process can be disrupted, only those cells would be affected. A process (or absence thereof) can be unique to some types of cancer, and not be present in others. In such a case, we would want a simple way to recognize whether a particular tumor possesses the unique trait or not. The implication of this question is whether…
Featuring Technion President Uri Sivan and Distinguished Professor and Nobel Laureate Aaron Ciechanover Moderated by Andrea Wolfe When all is said and done, the coronavirus pandemic brought seismic changes and new ethical questions to the world of medicine. And the Technion was ready. Learn about the Technion’s major initiative aimed at advancing the standard of […]
In the ongoing fight against cancer, Technion breakthroughs in diagnostics and treatments have improved and saved lives around the world. This year alone, scientists at the Rappaport Technion Integrated Cancer Center (RTICC) have advanced research on early detection of various cancers, curbing cancer metastasis, and personalized treatment. RTICC donors enjoyed an exclusive look at the […]
Virtual Event With Technion Alumni “From a young age, I knew I am going to be a scientist, and it’s a decision I have never regretted,” said Dr. Assaf Zinger. Today, he is a rising star in biomedical engineering and nanotherapeutics. Conducting his postdoctoral research at the Houston Methodist Research Institute in Texas, Dr. Zinger […]
Since the start of the pandemic, scientists have warned that cancer patients could be at increased risk of serious illness from COVID-19 due to a weakened immune system. But that commonly held belief, reinforced by an early study from China as well as the National Cancer Institute, might be wrong — for certain patients. In fact, cancer patients, with the exception of those with blood cancers, may not become infected any more than the population at large, and might have the same if not better odds of beating back the most severe symptoms of COVID-19. Those were the findings of…
People who have just learned they have a tumor face heart-wrenching questions such as: is it cancerous? Will it spread? Metastasis, the spread of cancer cells from the primary tumor to new areas of the body, is responsible for an alarming 90% of cancer-related deaths. But knowing the risk of metastasis early on can help determine the most effective treatment and improve the patient’s outcome. A research team led by Technion Professor Daphne Weihs of the Faculty of Biomedical Engineering has developed and tested a biomechanical technology to predict whether a tumor is cancerous, and if so, the likelihood of…